Search

Your search keyword '"Histoplasma growth & development"' showing total 261 results

Search Constraints

Start Over You searched for: Descriptor "Histoplasma growth & development" Remove constraint Descriptor: "Histoplasma growth & development"
261 results on '"Histoplasma growth & development"'

Search Results

101. Aberrant Histoplasma capsulatum. Confirmation of identity by a chemiluminescence-labeled DNA probe.

102. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules.

103. Diagnosis of systemic histoplasmosis in AIDS patients.

104. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts.

105. Mitochondrial activity and heat-shock response during morphogenesis in the pathogenic fungus Histoplasma capsulatum.

106. Intracellular growth inhibition of Histoplasma capsulatum induced in murine macrophages by recombinant gamma interferon is not due to a limitation of the supply of methionine or cysteine to the fungus.

107. A medium for inducing conversion of Histoplasma capsulatum var. capsulatum into its yeast-like form.

108. Recovery of Histoplasma capsulatum from blood in a commercial radiometric Mycobacterium medium.

109. Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatum.

110. Infection of P388D1 macrophages and respiratory epithelial cells by Histoplasma capsulatum: selection of avirulent variants and their potential role in persistent histoplasmosis.

111. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

112. Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum.

113. [Ultrastructural study of the yeast-mycelium transition in Histoplasma capsulatum. II. Changes at 34 degrees C].

114. [Histoplasma capsulatum infection, a manifestation of AIDS unusual for The Netherlands].

115. Temperature-sensitive variants of Histoplasma capsulatum isolated from patients with acquired immunodeficiency syndrome.

116. The effect of temperature on the ultrastructure of Histoplasma capsulatum during the mycelium-yeast transition.

117. [The use of exoantigens for identifying Histoplasma capsulatum].

118. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma.

119. Disseminated histoplasmosis in the acquired immunodeficiency syndrome.

120. T-cell hybridoma-produced lymphokine that activates macrophages to suppress intracellular growth of Histoplasma capsulatum.

121. Electron microscopy of yeastlike cell development from the microconidium of Histoplasma capsulatum.

122. Iron and host resistance in histoplasmosis.

123. Studies on histoplasmosis farciminosi (epizootic lymphangitis) in Egypt. Isolation of Histoplasma farciminosum from cases of histoplasmosis farciminosi in horses and its morphological characteristics.

125. The mycelial status and reversibility in Histoplasma capsulatum.

126. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.

127. Mycelium-yeast transition in Histoplasma capsulatum. Early ultrastructural changes.

128. Histoplasmosis in normal hosts.

129. Histoplasmosis.

131. Regulation of dimorphism in Histoplasma capsulatum by cyclic adenosine 3',5'-monophosphate.

132. Heat-shock proteins induced during the mycelial-to-yeast transitions of strains of Histoplasma capsulatum.

133. Balanced growth and morphogenesis of Histoplasma capsulatum in a defined synthetic medium.

134. Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum.

135. Hydroxamic acid from Histoplasma capsulatum that displays growth factor activity.

136. Ribonucleic acid polymerases of the yeast phase of Histoplasma capsulatum.

137. Histin, an RNA polymerase inhibitor isolated from Histoplasma capsulatum.

138. Preliminary studies on conidial liberation of Blastomyces dermatitidis and Histoplasma capsulatum.

139. Cave-associated histoplasmosis--Costa Rica.

140. RNA metabolism during morphogenesis in Histoplasma capsulatum.

141. Aspects of the dimorphism of Histoplasma farciminosum: a light and electron microscopic study.

142. Cysteine biosynthesis in a fungus, Histoplasma capsulatum.

143. Immunosuppression transfer by spleen cells from young to adult mice previous to Histoplasma capsulatum infection.

144. Antibiotic sensitivity of the yeast and mycelial phases of Histoplasma capsulatum.

146. Purification of membranes and identification of phase-specific proteins of the dimorphic pathogenic fungus Histoplasma capsulatum.

147. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores.

149. A rapid radiometric technique used to trap and quantitate 14CO2 evolved by slow-growing microorganisms.

150. Studies on experimental murine histoplasmosis: host protection and cellular immunity.

Catalog

Books, media, physical & digital resources